BNP Paribas Arbitrage SA lowered its stake in Vitamin Shoppe Inc. (NYSE:VSI) by 45.9% during the third quarter, Holdings Channel reports. The institutional investor owned 4,574 shares of the company’s stock after selling 3,887 shares during the period. BNP Paribas Arbitrage SA’s holdings in Vitamin Shoppe were worth $123,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Group LTD increased its position in Vitamin Shoppe by 7.3% in the first quarter. BlackRock Group LTD now owns 37,164 shares of the company’s stock worth $1,150,000 after buying an additional 2,521 shares during the period. Menta Capital LLC increased its position in Vitamin Shoppe by 102.9% in the first quarter. Menta Capital LLC now owns 14,200 shares of the company’s stock worth $440,000 after buying an additional 7,200 shares during the period. UBS Group AG increased its position in Vitamin Shoppe by 390.6% in the first quarter. UBS Group AG now owns 91,027 shares of the company’s stock worth $2,819,000 after buying an additional 72,471 shares during the period. Goldman Sachs Group Inc. increased its position in Vitamin Shoppe by 152.4% in the first quarter. Goldman Sachs Group Inc. now owns 104,812 shares of the company’s stock worth $3,245,000 after buying an additional 63,278 shares during the period. Finally, GW&K Investment Management LLC increased its position in Vitamin Shoppe by 12.4% in the second quarter. GW&K Investment Management LLC now owns 42,609 shares of the company’s stock worth $1,303,000 after buying an additional 4,694 shares during the period.
Vitamin Shoppe Inc. (NYSE:VSI) opened at 27.25 on Friday. The firm’s 50-day moving average price is $27.15 and its 200-day moving average price is $28.96. The company has a market cap of $642.66 million, a PE ratio of 15.96 and a beta of 0.55. Vitamin Shoppe Inc. has a 12-month low of $26.02 and a 12-month high of $34.41.
Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, August 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.59 by $0.04. The firm earned $332.70 million during the quarter, compared to analyst estimates of $331.58 million. Vitamin Shoppe had a net margin of 3.56% and a return on equity of 11.53%. Vitamin Shoppe’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.57 EPS. Equities research analysts forecast that Vitamin Shoppe Inc. will post $2.18 earnings per share for the current fiscal year.
A number of research analysts have recently weighed in on VSI shares. Zacks Investment Research downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Wednesday, August 3rd. Wedbush reissued an “outperform” rating and issued a $39.00 price target on shares of Vitamin Shoppe in a research note on Wednesday, August 3rd. Jefferies Group reissued a “hold” rating on shares of Vitamin Shoppe in a research note on Thursday, August 4th. Finally, Barclays PLC started coverage on Vitamin Shoppe in a research note on Thursday, September 22nd. They issued an “equal weight” rating and a $29.00 price target on the stock. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. Vitamin Shoppe has an average rating of “Hold” and an average price target of $32.27.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.